Characteristics of HIV-infected men with low serum testosterone levels

International Journal of STD and AIDS

Volumn 10, Issue 12, 1999, Pages 817-820

  Kopicko, Jeffrey J ^a,c   Momodu, I ^b   Adedokun, A ^b   Hoffman, M ^a   Clark, R A ^a   Kissinger, P ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY   (United States)

^c Section of Pulmonary Diseases   (United States)

Author keywords

HIV progression; HIV wasting syndrome; Hypotestosteronism

Indexed keywords

CD4 ANTIGEN; MEGESTROL ACETATE; TESTOSTERONE;

ADULT; ARTICLE; CANDIDIASIS; CLINICAL FEATURE; DEMENTIA; DEMOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; UNITED STATES; WASTING SYNDROME;

ADULT; AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDIASIS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ESOPHAGEAL DISEASES; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; LONGITUDINAL STUDIES; MALE; MEGESTROL ACETATE; PROGNOSIS; TESTOSTERONE;

EID: 0032746663     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991913466     Document Type: Article

References (14)

1. 1 Hellerstein M. Endocrinology abnormalities. In: Cohen PT, Sande M, Volberding P, eds. The AIDS Knowledge Base. Boston: Massachusetts Medical Society, 1990:1-5
2. 2 CDC. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1992;41:(RR-17)
3. 3 Laudat A, Blum L, Guechot J, et al. Changes in systemic gonadal and adrenal steroids in symptomatic human immunodeficiency virus infected men: relationship with CD4 cell counts. Eur J Endocrinol 1995;133:418-24
4. 4 Muurahainen N, Mulligan K. Clinical trial updates in human immunodeficiency virus wasting. Semin Oncol 1998;25:104-11
5. 5 Dobs A, Few III W, Blackman M, Harman S, Hoover D, Graham N. Serum hormones in men with human immunodeficiency virus associated wasting. J Clin Endocrinol Metab 1996;81:4108-12
6. 6 Anwar D, Hirschel B, Suvage M. Hypotestosteronism in the era of HAART [32275]. World AIDS Conference 1998
7. 7 Fields-Gardner C, Jennings G. Evaluation of serial observations of weight and body composition changes in HIV positive patients [32186]. World AIDS Conference 1998
8. 8 Vergel N, Savato P, Mooney M. Anabolic steroids, resistance exercise and protein supplementation effects on lean body mass in HIV-positive patients [32185]. World AIDS Conference 1998
9. 9 Grinspoon S, Anderson C, Schoenfeld D, et al. Long-term effects of androgen administration in men with AIDS wasting [32176]. World AIDS Conference 1998
10. 10 Berger D, Muurahainen N, Wittert H, et al. Hypogonadism and wasting in the era of HAART in HIV-infected patients [32174]. World AIDS Conference 1998
11. 11 Falutz J, Callow L. Testosterone, HIV activity, and nutritional status in HIV-infected women [32163]. World AIDS Conference 1998
12. 12 Laudat A, Blum L, Guechot J, et al. Changes in systemic gonadal and adrenal steroids in symptomatic human immunodeficiency virus infected men: relationship with CD4 cell counts. Eur J Endocrinol 1995;133:418-24
13. 13 Christeff N, Gharakhanian S, Thobie N, Roxenbaum W, Nunez E. Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5:841-6
14. 14 Wagner G, Rabkin J, Rabkin R. Illness stage, concurrent medications, and other correlates of low testosterone in men with HIV illness. J Acquir Immune Defic Syndr Hum Retrovirol 1995,8:204-7